Progyny (PGNY) analyst forecast and price target
Analyst forecast
Consensus of 11 analyst ratings
Based on 7 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Initiated Coverage | Overweight | $37.00 | Sep 30, 2026 |
| Citizens | Maintained | Market Outperform | $33.00 from $31.00 | Sep 8, 2026 |
| JP Morgan | Maintained | Neutral | $30.00 from $27.00 | Aug 21, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $37.00 | Aug 20, 2026 |
| Truist Securities | Maintained | Buy | $36.00 from $33.00 | Aug 13, 2026 |
| Barclays | Maintained | Equal-Weight | $30.00 from $34.00 | Aug 12, 2026 |
| Barclays | Downgraded | Overweight → Equal-Weight | $34.00 from $27.00 | Jul 28, 2026 |
| BTIG | Maintained | Buy | $40.00 from $30.00 | Jul 24, 2026 |
| Canaccord Genuity | Maintained | Buy | $36.00 from $30.00 | Jul 21, 2026 |
| Keybanc | Maintained | Overweight | $35.00 from $30.00 | Jul 13, 2026 |
| Truist Securities | Maintained | Buy | $33.00 from $30.00 | Jun 22, 2026 |
| B of A Securities | Maintained | Buy | $31.00 from $29.00 | Jun 2, 2026 |
| Canaccord Genuity | Upgraded | Hold → Buy | $30.00 from $19.00 | May 19, 2026 |
| Barclays | Maintained | Overweight | $27.00 from $23.00 | May 18, 2026 |
| Truist Securities | Maintained | Buy | $30.00 from $28.00 | May 11, 2026 |
| Citizens | Maintained | Market Outperform | $31.00 from $30.00 | May 11, 2026 |
| Barclays | Maintained | Overweight | $23.00 from $29.00 | Mar 20, 2026 |
| Canaccord Genuity | Maintained | Hold | $19.00 from $26.00 | Mar 11, 2026 |
| BTIG | Maintained | Buy | $30.00 from $35.00 | Mar 5, 2026 |
| Truist Securities | Maintained | Buy | $28.00 from $34.00 | Mar 2, 2026 |
Frequently asked questions
What is the price target for PGNY stock?
The average 12-month analyst price target for Progyny (PGNY) is $34.57, with a high estimate of $40.00 and a low of $30.00, across 7 analysts.
Is PGNY a buy, sell, or hold?
Analysts covering Progyny currently average a Buy rating: 9 buy, 2 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for PGNY?
The average price target of $34.57 implies 24.18% upside from the last price of $27.84.
What is the latest analyst rating on PGNY?
On Sep 30, 2026, Wells Fargo initiated coverage of Progyny at Overweight with a price target of $37.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.